Singular Genomics Systems
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Singular Genomics Systems's past years’ income statements indicate that its last revenue has increased compared to the previous period by 281% to $2,911,000. Profit margin reached -3257%. Total operating expenses were $102,243,000.

Profit Margin

Singular Genomics Systems, Inc. (NASDAQ:OMIC): Profit margin
2019 0 -12.34M
2020 0 -28.66M
2021 0 -98.88M
2022 765K -88.27M -11538.69%
2023 2.91M -94.82M -3257.3%

OMIC Income Statement (2019 – 2023)

2023 2022 2021 2020 2019
Revenue
Revenue
2.91M765K000
Cost of revenue
3.46M789K1.13M639K350K
Gross profit
-558K-24K-1.13M-639K-350K
Operating exp.
Research and development
47.76M46.19M32.65M21.24M10.48M
Selling and marketing
00000
Total operating expenses
102.24M93.46M61.27M27.53M12.77M
Operating income
-102.80M-93.48M-61.27M-27.53M-12.77M
Other income (expenses), net
7.98M2.60M-37.49M-411K446K
Income before tax
-94.82M-90.87M-98.77M-27.94M-12.32M
Income tax expense
0-2.60M118K718K17K
Net income
-94.82M-88.27M-98.88M-28.66M-12.34M
Earnings per share
Basic EPS
-39.08-1.24-1.37-12.41-0.18
Diluted EPS
-39.08-1.24-1.37-12.41-0.18
Data sourceData sourceData source